Pharma Targeting Launches Partner Identifier to Provide Business Opportunities
Service expected to help companies discover partners in funding.
Pharma Targeting, a pharmaceutical market intelligence and data company, has announced the launch of ‘Partner Identifier’, an initiative designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. According to the organization, the technology uses data-driven intelligence to help customers identify and engage with the right partner for licensing, in-licensing, funding, distribution, and other business needs.
“The Partner Identifier was born out of a client need, adjusted, and implemented to help them to identify and engage with the right partner, at the right time, with an aligning strategy and the necessary funds in place,” says Anil Kumar, founder, Pharma Targeting. “We do the challenging work of finding and contacting our clients’ potential partners, so that all they have to do is make connections and build relationships. The ultimate goal is helping our clients to achieve meaningful collaboration and partnership, and get their products to market quicker.”
Reference:
Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients. (2023, July 6).
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
